Pancreatic Cancer Research

ResearcherTang Du HospitalActive in the last 2 years

Qing Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3882-6540; OpenAlex author ID A5100434827. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Direct regulation of FNIP1 and FNIP2 by MEF2 sustains MTORC1 activation and tumor progression in pancreatic cancer. Co-author DOI 10.1080/15548627.2023.2259735↗
  2. Label-Free Quantitative Proteomics Unravels Carboxypeptidases as the Novel Biomarker in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1016/j.tranon.2018.03.005↗
  3. Expression of A20 is reduced in pancreatic cancer tissues. Co-author DOI 10.1007/s10735-012-9402-6↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qian Yang · 1 shared paper, 2024 · strength 0.19
  2. Xiaobin Li · 1 shared paper, 2024 · strength 0.19
  3. Xia Li · 1 shared paper, 2024 · strength 0.19
  4. Yang Song · 1 shared paper, 2018 · strength 0.08
  5. Desheng Wang · 1 shared paper, 2018 · strength 0.08
  6. Haichuan Su · 1 shared paper, 2018 · strength 0.08
  7. Jianguo Lu · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.